"A multi-specialty clinical research center dedicated to making a difference in our local and global community, to better our health today and in the future."

During the past decade, iResearch Savannah conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "iResearch Savannah" #1 sponsor was "Biohaven Pharmaceuticals, Inc." with 3 trials, followed by "Amgen" with 2 trials sponsored, "Athira Pharma" with 2 trials sponsored, "ModernaTX, Inc." with 1 trials sponsored and "NeuroRx, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "iResearch Savannah" #1 collaborator was "Novartis" with 2 trials as a collaborator, "ClinEdge, LLC" with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator and "Navitas Clinical Research, Inc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "iResearch Savannah" are "Alzheimer Disease" (4 trials), "Migraine" (2 trials), "Obsessive-Compulsive Disorder" (2 trials), "Bipolar Depression" (1 trials) and "Cannabis Withdrawal" (1 trials). Many other conditions were trialed in "iResearch Savannah" in a lesser frequency.

Most popular intervention types in "iResearch Savannah" are "Drug" (10 trials), "Other" (3 trials), "Combination Product" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "ATH-1017" (2 trials), "Erenumab Dose 1" (2 trials), "Erenumab Dose 2" (2 trials) and "Erenumab Dose 3" (2 trials). Other intervention names were less common.

The vast majority of trials in "iResearch Savannah" are 13 trials for "All" genders.

Currently, there are NaN active trials in "iResearch Savannah". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 2 completed trials in iResearch Savannah, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in iResearch Savannah, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".